Tatva Chintan Pharma Chem Faces Mixed Technical Trends Amid Market Volatility
2025-04-03 08:06:20Tatva Chintan Pharma Chem, a small-cap player in the chemicals industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 728.00, showing a notable increase from the previous close of 705.20. Over the past year, the stock has experienced significant volatility, with a 52-week high of 1,319.40 and a low of 620.60. In terms of technical indicators, the weekly MACD suggests a mildly bullish sentiment, while the monthly perspective leans towards a mildly bearish outlook. The Bollinger Bands and moving averages also indicate a mildly bearish trend on both weekly and monthly scales. The KST reflects a bearish stance, further emphasizing the mixed signals present in the technical summary. When comparing the stock's performance to the Sensex, Tatva Chintan has shown a 3.04% return over the past week, contrasting with a decline of 0.87% in the S...
Read More
Tatva Chintan Pharma Chem Faces Significant Volatility Amid Ongoing Financial Struggles
2025-03-17 09:57:06Tatva Chintan Pharma Chem has faced notable volatility, hitting a new 52-week low and underperforming its sector. The company has reported a significant decline in net sales and operating profit over the past five years, alongside negative results for the last 12 quarters, raising concerns about its financial health.
Read More
Tatva Chintan Pharma Chem Faces Ongoing Challenges Amid Significant Stock Volatility
2025-03-17 09:57:05Tatva Chintan Pharma Chem has faced notable volatility, hitting a new 52-week low and underperforming its sector. The company has reported declining net sales and operating profit over the past five years, alongside negative results for 12 consecutive quarters, raising concerns about its financial health and market position.
Read More
Tatva Chintan Pharma Chem Faces Persistent Decline Amid Ongoing Financial Struggles
2025-03-17 09:57:04Tatva Chintan Pharma Chem has faced notable volatility, hitting a new 52-week low and experiencing a three-day decline. The stock is trading below multiple moving averages and has seen a significant annual decrease. The company has reported negative financial results for 12 consecutive quarters, with declining sales and profits.
Read More
Tatva Chintan Pharma Chem Faces Ongoing Challenges Amid Significant Stock Volatility
2025-03-17 09:57:02Tatva Chintan Pharma Chem has faced notable volatility, hitting a 52-week low and experiencing a significant decline over the past year. The company has reported consecutive quarterly losses, with net sales and operating profit decreasing sharply. Its stock performance remains below key moving averages, indicating ongoing challenges.
Read More
Tatva Chintan Pharma Chem Reaches All-Time Low Amid Ongoing Financial Struggles
2025-03-17 09:32:28Tatva Chintan Pharma Chem has faced notable volatility, hitting an all-time low and experiencing a three-day losing streak. The stock has underperformed in the chemicals sector, with significant declines over various time frames. Financial metrics reveal ongoing challenges, including declining sales and operating profit, alongside a low return on capital employed.
Read More
Tatva Chintan Pharma Chem Faces Significant Decline Amid Ongoing Financial Struggles
2025-03-13 12:07:58Tatva Chintan Pharma Chem has faced notable volatility, hitting a 52-week low and underperforming its sector. The stock has declined significantly over the past year, with persistent negative financial results, including declining net sales and operating profit. Concerns about its high valuation relative to peers persist.
Read More
Tatva Chintan Pharma Chem Hits All-Time Low Amid Ongoing Financial Struggles
2025-03-13 11:47:05Tatva Chintan Pharma Chem has faced notable volatility, hitting an all-time low and underperforming its sector. The company has reported negative financial results for 12 consecutive quarters, with declining sales and operating profit. Its low return on capital employed and high valuation relative to peers raise concerns about its financial health.
Read More
Tatva Chintan Pharma Chem Faces Market Challenges Amid Recent Trading Activity
2025-02-19 09:37:57Tatva Chintan Pharma Chem has seen notable trading activity, hitting a new 52-week low while also experiencing a slight recovery today. Despite recent declines, the stock has outperformed its sector. However, it remains below key moving averages, indicating ongoing challenges in its market position.
Read MoreCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
03-Apr-2025 | Source : BSECertificate under Reg. 74(5) of SEBI (DP) Regulations 2018
Closure of Trading Window
26-Mar-2025 | Source : BSEIntimation of Closure of Trading Window
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
24-Mar-2025 | Source : BSEIntimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
Corporate Actions
No Upcoming Board Meetings
Tatva Chintan Pharma Chem Ltd has declared 20% dividend, ex-date: 06 Sep 24
No Splits history available
No Bonus history available
No Rights history available